Paul Tudor Jones's CNMD Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 30,208 shares of CONMED Corporation (CNMD) worth $1.4 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in CNMD, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 83,418 shares. Largest reduction occurred in Q1 2026, reducing 82,089 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's CONMED Corporation (CNMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CONMED Corporation (CNMD) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +6,905 | Add 29.63% | 30,208 | $46.23 |
| Q2 2026 | +23,303 | New Buy | 23,303 | $32.73 |
| Q1 2026 | -82,089 | Sold Out | 0 | $0.00 |
| Q4 2025 | -42,855 | Reduce 34.30% | 82,089 | $40.60 |
| Q3 2025 | +83,418 | Add 200.88% | 124,944 | $47.03 |
| Q2 2025 | +41,526 | New Buy | 41,526 | $52.08 |
| Q4 2024 | -49,285 | Sold Out | 0 | $0.00 |
| Q3 2024 | -59,036 | Reduce 54.50% | 49,285 | $71.92 |
| Q2 2024 | -5,110 | Reduce 4.50% | 108,321 | $69.32 |
| Q1 2024 | +36,187 | Add 46.85% | 113,431 | $80.08 |
| Q4 2023 | -1,182 | Reduce 1.51% | 77,244 | $109.51 |
| Q3 2023 | +62,677 | Add 397.97% | 78,426 | $100.85 |
| Q2 2023 | -48,726 | Reduce 75.57% | 15,749 | $135.89 |
| Q1 2023 | +11,274 | Add 21.19% | 64,475 | $0.10 |
| Q4 2022 | -28,573 | Reduce 34.94% | 53,201 | $0.09 |
| Q3 2022 | +8,944 | Add 12.28% | 81,774 | $80.17 |
| Q2 2022 | +47,650 | Add 189.24% | 72,830 | $95.76 |
| Q1 2022 | +25,180 | New Buy | 25,180 | $148.53 |
| Q4 2020 | -4,511 | Sold Out | 0 | $0.00 |
| Q3 2020 | -12,351 | Reduce 73.25% | 4,511 | $78.70 |
| Q2 2020 | -7,650 | Reduce 31.21% | 16,862 | $72.00 |
| Q1 2020 | +14,432 | Add 143.17% | 24,512 | $57.28 |
| Q4 2019 | +4,721 | Add 88.09% | 10,080 | $111.81 |
| Q3 2019 | +5,359 | New Buy | 5,359 | $96.10 |
| Q1 2016 | -5,000 | Sold Out | 0 | $0.00 |
| Q4 2015 | -1,500 | Reduce 23.08% | 5,000 | $44.00 |
| Q3 2015 | +6,500 | New Buy | 6,500 | $47.69 |
| Q1 2015 | -8,180 | Sold Out | 0 | $0.00 |
| Q4 2014 | -16,462 | Reduce 66.80% | 8,180 | $44.99 |
| Q3 2014 | +2,272 | Add 10.16% | 24,642 | $36.85 |
| Q2 2014 | -2,553 | Reduce 10.24% | 22,370 | $44.17 |
| Q1 2014 | +17,623 | Add 241.41% | 24,923 | $43.45 |
| Q4 2013 | -3,800 | Reduce 34.23% | 7,300 | $42.47 |
| Q3 2013 | -16,700 | Reduce 60.07% | 11,100 | $33.96 |
| Q2 2013 | +27,800 | Add 0.00% | 27,800 | $31.22 |
Paul Tudor Jones's CONMED Corporation Investment FAQs
Paul Tudor Jones first purchased CONMED Corporation (CNMD) in Q2 2013, acquiring 27,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held CONMED Corporation (CNMD) for 35 quarters since Q2 2013.
Paul Tudor Jones's largest addition to CONMED Corporation (CNMD) was in Q3 2025, adding 124,944 shares worth $5.88 M.
According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 30,208 shares of CONMED Corporation (CNMD), valued at approximately $1.4 M.
As of the Q3 2026 filing, CONMED Corporation (CNMD) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in CONMED Corporation (CNMD) was 124,944 shares, as reported at the end of Q3 2025.